home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

The Sunshine Act - Have you seen the light?

 
  September 04, 2013  
     
 
ComplianceOnline, Grand Hyatt San Francisco 345 Stockton Street
2013-09-26


The Final Rule for the Physician Payment Sunshine Act (Sunshine Act) is out! New federal legislation governs relationships between physicians and medical device, drug, and biotech manufacturers. The Sunshine Act requires detailed reporting in 2014 of ''transfers of value'' made in 2013 to physicians and teaching hospitals as well as physician ownership in companies. The information reported will be made public by CMS (Centers for Medicare and Medicaid Services) and penalties for non-compliance are substantial.

Are you aware of changes made between the Proposed Rule and the Final Rule of Physician Payment Sunshine Act (Sunshine Act)? Are you prepared to track and report gifts and payments made to physicians and teaching hospitals? Is your CEO, CFO or CCO prepared to certify your prospective submission in March of 2014? Are you prepared to report physician ownership? Are you sure the Sunshine Act applies to you? This one day in-person seminar will review the Final Rule of Sunshine Act, walk you through real world examples, and provide an opportunity for you to ask questions.

This program will go beyond the nuts and bolts and into some strategic and tactical considerations to keep in mind while implementing policies and producers designed to assure compliance with the Sunshine Act. The first half of the program will be devoted for explaining the regulation and how it applies to your company. The second half of the program will involve an interactive workshop and focus on internal policy development.

This seminar is being led by Mark Gardner who will put his M.B.A. and past decade of sales and marketing experience, along with his legal degree, in teaching. It will be important and beneficial for companies impacted by the Sunshine Act.

 
 
Organized by: ComplianceOnline
Invited Speakers: Mark Gardner, M.B.A., J.D.,
Attorney and Adjunct Professor at DuVal & Associates

Mark Gardner, M.B.A., J.D., is an attorney at DuVal & Associates, P.A., a law firm dedicated to counseling companies in the medical device, dietary supplement, drug, biotech, and food industries

 
Deadline for Abstracts: 2013-09-25
 
Registration: http://www.complianceonline.com/ecommerce/control/seminar?product_id=80117SEM&?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.